ClinConnect ClinConnect Logo
Search / Trial NCT06875362

Probiotic LR08 Improves Gut and Metabolism

Launched by WECARE PROBIOTICS CO., LTD. · Mar 8, 2025

Trial Information

Current as of June 27, 2025

Not yet recruiting

Keywords

Probiotics Efficacy Safety Gut Microbiota Immune Function

ClinConnect Summary

This clinical trial is studying a dietary supplement called LR08, which is a type of probiotic. Probiotics are beneficial bacteria that can help improve our gut health and support our immune system. The trial aims to see if taking LR08 can enhance intestinal health compared to a placebo (a harmless substance with no active ingredients) in healthy adults.

To be eligible for this study, participants need to be between the ages of 18 and 65, willing to attend three follow-up visits, and agree to provide some health samples (like blood and stool) during the trial. It's important that participants do not have certain digestive diseases or serious neurological conditions, and they should not be currently receiving treatment for mental health issues. If you choose to participate, you can expect to visit the study site for assessments and learn more about how probiotics might benefit your health. This trial is currently not yet recruiting participants, but it could be an exciting opportunity for those who qualify!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Willing to attend 3 follow-up visits during the intervention period
  • 2. Agree to provide blood, urine, and stool samples twice during the intervention period
  • 3. Good eyesight, able to read and write, and capable of wearing glasses if needed
  • 4. Good hearing and able to fully comprehend all instructions during the intervention
  • Exclusion Criteria:
  • 1. Presence of digestive diseases, particularly gastrointestinal disorders (e.g., celiac disease, ulcerative colitis, Crohn's disease)
  • 2. History of serious neurological conditions (e.g., epilepsy, stroke, severe head trauma, meningitis within the last 10 years, brain surgery, brain tumor, or prolonged coma-not including general anesthesia)
  • 3. History of or currently receiving treatment for mental health disorders such as alcohol/drug/substance abuse, schizophrenia, psychosis, or bipolar disorder
  • 4. Currently taking medication for depression or low mood
  • 5. Presence of internal organ failure (e.g., heart, liver, or kidney failure)
  • 6. History of radiation therapy or chemotherapy treatments
  • 7. Underwent general anesthesia within the past three years or are scheduled for general anesthesia within the next 3 months during the trial period
  • 8. History of hepatitis (B or C), HIV, or syphilis

About Wecare Probiotics Co., Ltd.

wecare probiotics co., ltd. is a leading biotechnology firm dedicated to advancing gut health through innovative probiotic solutions. With a robust portfolio of research and development initiatives, the company focuses on formulating high-quality probiotic products that are backed by scientific evidence. Committed to enhancing the well-being of individuals, wecare probiotics collaborates with healthcare professionals and academic institutions to conduct clinical trials that evaluate the efficacy and safety of its formulations. The company's mission is to empower consumers with effective, research-driven probiotic options, fostering a healthier future for all.

Locations

Zhengzhou, Henan, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported